Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

The emerging role of Twist proteins in hematopoietic cells and hematological malignancies.

Merindol N, Riquet A, Szablewski V, Eliaou JF, Puisieux A, Bonnefoy N.

Blood Cancer J. 2014 Apr 25;4:e206. doi: 10.1038/bcj.2014.22. Review. Erratum in: Blood Cancer J. 2014 Oct;4:e254.

2.

Twist as a new prognostic marker in hematological malignancies.

Norozi F, Ahmadzadeh A, Shahjahani M, Shahrabi S, Saki N.

Clin Transl Oncol. 2016 Feb;18(2):113-24. doi: 10.1007/s12094-015-1357-0. Epub 2015 Jul 24. Review.

PMID:
26203802
3.

Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.

Wang T, Li Y, Wang W, Tuerhanjiang A, Wu Z, Yang R, Yuan M, Ma D, Wang W, Wang S.

Hum Pathol. 2014 Sep;45(9):1839-46. doi: 10.1016/j.humpath.2014.05.001. Epub 2014 May 24.

PMID:
24974259
4.

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.

Galván JA, Helbling M, Koelzer VH, Tschan MP, Berger MD, Hädrich M, Schnüriger B, Karamitopoulou E, Dawson H, Inderbitzin D, Lugli A, Zlobec I.

Oncotarget. 2015 Jan 20;6(2):874-85.

5.

Biological function and molecular mechanism of Twist2.

Chengxiao Z, Ze Y.

Yi Chuan. 2015 Jan;37(1):17-24. doi: 10.16288/j.yczz.2015.01.003. Review.

PMID:
25608809
6.

Autophagy deficiency stabilizes TWIST1 to promote epithelial-mesenchymal transition.

Qiang L, He YY.

Autophagy. 2014 Oct 1;10(10):1864-5. doi: 10.4161/auto.32171. Epub 2014 Aug 13.

7.

Redundant or separate entities?--roles of Twist1 and Twist2 as molecular switches during gene transcription.

Franco HL, Casasnovas J, Rodríguez-Medina JR, Cadilla CL.

Nucleic Acids Res. 2011 Mar;39(4):1177-86. doi: 10.1093/nar/gkq890. Epub 2010 Oct 8. Review.

8.

MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.

Dong P, Kaneuchi M, Watari H, Sudo S, Sakuragi N.

Mol Carcinog. 2014 May;53(5):349-59. doi: 10.1002/mc.21983. Epub 2013 Sep 3.

PMID:
24002805
9.

Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Buehler D, Hardin H, Shan W, Montemayor-Garcia C, Rush PS, Asioli S, Chen H, Lloyd RV.

Mod Pathol. 2013 Jan;26(1):54-61. doi: 10.1038/modpathol.2012.137. Epub 2012 Aug 17.

10.

Oxidative stress drives disulfide bond formation between basic helix-loop-helix transcription factors.

Danciu TE, Whitman M.

J Cell Biochem. 2010 Feb 1;109(2):417-24. doi: 10.1002/jcb.22415.

PMID:
19950203
11.

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.

Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A.

Cancer Cell. 2008 Jul 8;14(1):79-89. doi: 10.1016/j.ccr.2008.06.005.

12.

Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma.

Sun T, Sun BC, Zhao XL, Zhao N, Dong XY, Che N, Yao Z, Ma YM, Gu Q, Zong WK, Liu ZY.

Hepatology. 2011 Nov;54(5):1690-706. doi: 10.1002/hep.24543. Epub 2011 Jul 21.

PMID:
21748764
13.

Twist1 transcriptional targets in the developing atrio-ventricular canal of the mouse.

Vrljicak P, Cullum R, Xu E, Chang AC, Wederell ED, Bilenky M, Jones SJ, Marra MA, Karsan A, Hoodless PA.

PLoS One. 2012;7(7):e40815. doi: 10.1371/journal.pone.0040815. Epub 2012 Jul 16.

14.

Twist1 directly regulates genes that promote cell proliferation and migration in developing heart valves.

Lee MP, Yutzey KE.

PLoS One. 2011;6(12):e29758. doi: 10.1371/journal.pone.0029758. Epub 2011 Dec 29.

15.

The basic helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates Twist1 through an E-box element.

Suzuki M, Sato F, Bhawal UK.

Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):390-5. doi: 10.1016/j.bbrc.2014.11.030. Epub 2014 Nov 18.

PMID:
25446074
16.

Phosphorylation of the Twist1-family basic helix-loop-helix transcription factors is involved in pathological cardiac remodeling.

Lu S, Nie J, Luan Q, Feng Q, Xiao Q, Chang Z, Shan C, Hess D, Hemmings BA, Yang Z.

PLoS One. 2011 Apr 29;6(4):e19251. doi: 10.1371/journal.pone.0019251.

17.

Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas.

Gasparotto D, Polesel J, Marzotto A, Colladel R, Piccinin S, Modena P, Grizzo A, Sulfaro S, Serraino D, Barzan L, Doglioni C, Maestro R.

Oncotarget. 2011 Dec;2(12):1165-75.

18.

The basic helix loop helix transcription factor Twist1 is a novel regulator of ATF4 in osteoblasts.

Danciu TE, Li Y, Koh A, Xiao G, McCauley LK, Franceschi RT.

J Cell Biochem. 2012 Jan;113(1):70-9. doi: 10.1002/jcb.23329.

19.

Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation.

Schmidt JM, Panzilius E, Bartsch HS, Irmler M, Beckers J, Kari V, Linnemann JR, Dragoi D, Hirschi B, Kloos UJ, Sass S, Theis F, Kahlert S, Johnsen SA, Sotlar K, Scheel CH.

Cell Rep. 2015 Jan 13;10(2):131-9. doi: 10.1016/j.celrep.2014.12.032. Epub 2015 Jan 8.

20.

Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells.

Zhu K, Chen L, Han X, Wang J, Wang J.

Oncol Rep. 2012 Apr;27(4):1027-34. doi: 10.3892/or.2012.1633. Epub 2012 Jan 12.

Supplemental Content

Support Center